SCHEMBL6511005

SCHEMBL6511005

CC(CCCN(CCCC(C)(c1ccccc1)C1CCOC1=O)C(N)=S)(c1ccccc1)C1CCOC1=O

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6509705 0.89 LMNA (0.32) LMNA
SCHEMBL6391462 0.80 RAB9A (0.37) LMNA
SCHEMBL6510631 0.79 LMNA (0.33) LMNA
SCHEMBL8745049 0.78 SSTR4 (0.33)
SCHEMBL6515537 0.78 LMNA (0.31) LMNA
SCHEMBL6508420 0.78 LMNA (0.31) LMNA
SCHEMBL2737103 0.77 ACACB (0.35) LMNA
SCHEMBL6898799 0.75 ALDH1A1 (0.31)
SCHEMBL314331 0.70 LMNA (0.38) LMNA
SCHEMBL6512880 0.68 LMNA (0.39) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005068420-A1 UREA AND THIOUREA COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2005-07-28 WO claimed
WO-2005068420-A1 UREA AND THIOUREA COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2005-07-28 WO disclosed